CCL2 and atherosclerosis: Its sublingual immunization suppressed vascular lesion formation by reducing the expressions of CRP, MCP-1, and ox-LDL; therefore, this vaccine was suggested as a promising therapeutic factor to suppress P. gingivalis-mediated atherosclerosis.